The ORACLE test may be capable of predicting lung cancer survival at the point of diagnosis more effectively than currently used clinical risk factors, according to a recent study published by Biswas et al in Nature Cancer. The findings could help physicians make more informed treatment decisions for patients with stage I lung cancer and reduce the risk of cancer recurrence and metastasis.
Background
The ORACLE test was developed in 2019 to overcome the lack of biological markers in…
Article Source
https://ascopost.com/news/january-2025/oracle-test-may-predict-survival-in-early-stages-of-lung-cancer/
/Oracle%20Corp_%20logo%20on%20phone%20and%20stock%20data-by%20Rokas%20Tenys%20via%20Shutterstock.jpg?ssl=1 "If Oracle Scores a New Air Force Victory, Should You Buy, Sell or Hold ORCL Stock?")
